Tribunal suspected that Halep was blood doping at last year’s Wimbledon

The independent tribunal that banned Simona Halep for four years for doping had “strong grounds for suspicion” that the Romanian was also blood doping at last year’s Wimbledon, its newly published 125-page decision reveals. However, it could not be “comfortably satisfied” that was the case as the 31-year-old did not have any blood tests between April and September 2022.

On Tuesday the former world No 1 was found to have intentionally taken the banned blood‑doping agent roxadustat after a test at the 2022 US Open in August. Separately, an expert panel also found that Halep had abnormalities in her athlete biological passport after an analysis of 51 of her blood samples.

However the full decision, released on Thursday, reveals that the International Tennis Integrity Agency pushed for a more severe punishment and believed that she had blood doped from at least March 2022 in preparation for Wimbledon and the US Open that year.

In response the panel stated: “A key allegation by the ITIA on aggravating circumstances is that the player must have been using one prohibited substance or prohibited method from March 2022 at the latest. However, although there are strong grounds for suspicion we are not comfortably satisfied that this is so.

“By contrast with their opinion relating to August 2022 and the US Open, there is no unequivocal assertion by the expert panel that the blood doping by the player was ‘highly likely’. The same applies to the allegation of blood doping in connection with the Wimbledon championships in June/July 2022… There is a period from 27 April to 22 September for which the player’s blood values are unknown.”

Halep, who won the French Open in 2018 and Wimbledon a year later, insists she will fight the decision at the court of arbitration for sport after pleading her innocence. In a statement she said: “I am continuing to train and do everything in my power to clear my name of these false allegations.”

Meanwhile the full decision into Halep’s case also states that the panel believed it was “not realistically possible” that the levels of roxadustat in her body could have come from a Keto MCT supplement, as the Romanian had alleged.

While accepting that the supplement may have been tainted, something that experts disagreed over, it said that the levels in her body meant that she must have ingested roxadustat from “another source never identified”.

As part of the case, a woman of a similar height and stature was given the same amount of Keto MCT as Halep before her positive test. However the control study found that the values of the banned drug in Halep’s urine test were between “46 and 85 times higher” than in the highest value of the volunteer’s urine.

One expert told the tribunal that Halep would have needed to take between 900 and 5,000 times the recommended serving size of Keto MCT to produce the estimated concentrations of roxadustat in her sample, based on the player’s explanation and what was known about the metabolism of the drug. “He did not consider that plausible, or in line with what the player says she ingested,” the report states.

The full verdict also reveals that Halep did not disclose the Keto MCT supplement on her doping control form for her urine test on 29 August 2022 or mention it in her 26 October 2022 interview with the ITIA.

“In cross-examination at the June hearing, she said that for the DCF she had forgotten and that at the interview she had also probably just forgotten,” the report states. “That was distinctly careless of her, especially at the interview when the need for complete openness would have been even more apparent.”